Skip to main content
Top
Published in: Journal of Inflammation 1/2014

Open Access 01-12-2014 | Research

Early effects of Staphylococcus aureus biofilm secreted products on inflammatory responses of human epithelial keratinocytes

Authors: Amy Tankersley, Mark Barton Frank, Melissa Bebak, Robert Brennan

Published in: Journal of Inflammation | Issue 1/2014

Login to get access

Abstract

Background

Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers contribute to a considerable amount of mortality in the U.S. annually. The inability of these wounds to heal has now been associated with the presence of microbial biofilms. The aim of this study was to determine if products secreted by S. aureus biofilms play an active role in chronic wounds by promoting inflammation, which is a hallmark of chronic wounds.

Methods

In vitro experiments were conducted to examine changes in gene expression profiles and inflammatory response of human epithelial keratinocytes (HEKa) exposed to products secreted by S. aureus grown in biofilms or products secreted by S. aureus grown planktonically.

Results

After only two hours of exposure, gene expression microarray data showed marked differences in inflammatory, apoptotic, and nitric oxide responses between HEKa cells exposed to S. aureus biofilm conditioned media (BCM) and HEKa cells exposed to S. aureus planktonic conditioned media (PCM). As early as 4 hours post exposure, ELISA results showed significant increases in IL-6, IL-8, TNFα, and CXCL2 production by HEKa cells exposed to BCM compared to HEKa cells exposed to PCM or controls. Nitric oxide assay data also showed significant increases in nitric oxide production by HEKa cells treated with BCM compared to HEKa cells treated with PCM, or controls.

Conclusions

Taken together, these results support and extend previous findings that indicate products secreted by S. aureus biofilms directly contribute to the chronic inflammation associated with chronic wounds.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beckrich K, Aronovitch SA: Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. Nurs Econ. 1999, 17: 263-271.PubMed Beckrich K, Aronovitch SA: Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. Nurs Econ. 1999, 17: 263-271.PubMed
2.
go back to reference Boyko EJ, Ahroni JH, Smith DG, Davignon D: Increased mortality associated with diabetic foot ulcers. Diabetic Med. 1996, 13 (11): 967-972. 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K.PubMedCrossRef Boyko EJ, Ahroni JH, Smith DG, Davignon D: Increased mortality associated with diabetic foot ulcers. Diabetic Med. 1996, 13 (11): 967-972. 10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K.PubMedCrossRef
3.
go back to reference Landi F, Onder G, Russo A, Bernabei R: Pressure ulcer and mortality in frail elderly people living in community. Arch Gerontol Geriat. 2007, 44: 217-223.CrossRef Landi F, Onder G, Russo A, Bernabei R: Pressure ulcer and mortality in frail elderly people living in community. Arch Gerontol Geriat. 2007, 44: 217-223.CrossRef
4.
go back to reference Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA: Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006, 3 (3): 225-231. 10.1111/j.1742-481X.2006.00159.x.PubMedCrossRef Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA: Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006, 3 (3): 225-231. 10.1111/j.1742-481X.2006.00159.x.PubMedCrossRef
5.
go back to reference James GA, Swogger E, Wolcott R, Pulcini E, Secor J, Sestrich J, Costerton JW, Stewart PS: Biofilms in chronic wounds. Wound Repair Regen. 2008, 16 (1): 37-44. 10.1111/j.1524-475X.2007.00321.x.PubMedCrossRef James GA, Swogger E, Wolcott R, Pulcini E, Secor J, Sestrich J, Costerton JW, Stewart PS: Biofilms in chronic wounds. Wound Repair Regen. 2008, 16 (1): 37-44. 10.1111/j.1524-475X.2007.00321.x.PubMedCrossRef
6.
go back to reference Serralta VW, Harrison Belestra C, Cazzaniga AL, Davis SC, Mertz PM: Lifestyles of bacteria in wounds: presence of biofilms?. Wounds. 2001, 13: 29-34. Serralta VW, Harrison Belestra C, Cazzaniga AL, Davis SC, Mertz PM: Lifestyles of bacteria in wounds: presence of biofilms?. Wounds. 2001, 13: 29-34.
7.
go back to reference Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet. 2001, 358 (9276): 135-138. 10.1016/S0140-6736(01)05321-1.PubMedCrossRef Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms. Lancet. 2001, 358 (9276): 135-138. 10.1016/S0140-6736(01)05321-1.PubMedCrossRef
8.
go back to reference Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS: Loss of viability and induction in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair and Reg. 2009, 17 (5): 690-699. 10.1111/j.1524-475X.2009.00523.x.CrossRef Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS: Loss of viability and induction in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair and Reg. 2009, 17 (5): 690-699. 10.1111/j.1524-475X.2009.00523.x.CrossRef
9.
go back to reference Gotz F: Staphylococcus and biofilms. Mol Microbiol. 2002, 43 (6): 1367-1378. 10.1046/j.1365-2958.2002.02827.x.PubMedCrossRef Gotz F: Staphylococcus and biofilms. Mol Microbiol. 2002, 43 (6): 1367-1378. 10.1046/j.1365-2958.2002.02827.x.PubMedCrossRef
10.
go back to reference Fuqua WC, Winans SC, Greenberg EP: Quorum sensing in bacteria: the LuxR-LuxI Family of cell density-responsive transcriptional regulators. J Bacteriol. 1994, 176 (2): 269-275.PubMedPubMedCentral Fuqua WC, Winans SC, Greenberg EP: Quorum sensing in bacteria: the LuxR-LuxI Family of cell density-responsive transcriptional regulators. J Bacteriol. 1994, 176 (2): 269-275.PubMedPubMedCentral
11.
go back to reference Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS: Global gene expression in Staphylococcus aureus biofilms. J Bacteriol. 2004, 186: 4665-4684. 10.1128/JB.186.14.4665-4684.2004.PubMedPubMedCentralCrossRef Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS: Global gene expression in Staphylococcus aureus biofilms. J Bacteriol. 2004, 186: 4665-4684. 10.1128/JB.186.14.4665-4684.2004.PubMedPubMedCentralCrossRef
12.
go back to reference Crampton SE, Gerke C, Schnell NF, Nichols WW: Götz. The intracellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999, 67: 5427-5433. Crampton SE, Gerke C, Schnell NF, Nichols WW: Götz. The intracellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999, 67: 5427-5433.
13.
go back to reference Valle JA, Toledo-Arana A, Berasain C, Ghigo J, Amorena B, Penades JR, Lasa I: SarA and not δB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol. 2003, 48: 1075-1087. 10.1046/j.1365-2958.2003.03493.x.PubMedCrossRef Valle JA, Toledo-Arana A, Berasain C, Ghigo J, Amorena B, Penades JR, Lasa I: SarA and not δB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol. 2003, 48: 1075-1087. 10.1046/j.1365-2958.2003.03493.x.PubMedCrossRef
14.
go back to reference Beenken KE, Blevins JS, Smeltzer MS: Mutation of sar A in Staphylococcus aureus limits biofilm formation. Infect Immun. 2003, 71: 4206-4211. 10.1128/IAI.71.7.4206-4211.2003.PubMedPubMedCentralCrossRef Beenken KE, Blevins JS, Smeltzer MS: Mutation of sar A in Staphylococcus aureus limits biofilm formation. Infect Immun. 2003, 71: 4206-4211. 10.1128/IAI.71.7.4206-4211.2003.PubMedPubMedCentralCrossRef
15.
go back to reference Deluané A, Dubrac S, Blanchet C, Poupel O, Mäder U, Hiron A, Leduc A, Fitting C, Nicolas P, Cavaillon J-M, Adib-Conquy M, Msadek T: The WalkR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect Immun. 2012, 80: 3438-3453. 10.1128/IAI.00195-12.CrossRef Deluané A, Dubrac S, Blanchet C, Poupel O, Mäder U, Hiron A, Leduc A, Fitting C, Nicolas P, Cavaillon J-M, Adib-Conquy M, Msadek T: The WalkR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response. Infect Immun. 2012, 80: 3438-3453. 10.1128/IAI.00195-12.CrossRef
16.
go back to reference Resch A, Rosenstein R, Nerz C, Götz F: Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol. 2005, 71: 2663-2676. 10.1128/AEM.71.5.2663-2676.2005.PubMedPubMedCentralCrossRef Resch A, Rosenstein R, Nerz C, Götz F: Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol. 2005, 71: 2663-2676. 10.1128/AEM.71.5.2663-2676.2005.PubMedPubMedCentralCrossRef
17.
go back to reference Thurlow LR, Hanke MI, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen II, Bayles KW, Horswill AR, Kielian T: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol. 2011, 186 (11): 6585-6596. 10.4049/jimmunol.1002794.PubMedPubMedCentralCrossRef Thurlow LR, Hanke MI, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen II, Bayles KW, Horswill AR, Kielian T: Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol. 2011, 186 (11): 6585-6596. 10.4049/jimmunol.1002794.PubMedPubMedCentralCrossRef
18.
go back to reference Schierle CF, De la Garza M, Mustoe TA, Galiano RD: Staphylococcal biofilms impair wound healing by delaying reepithelialzation in a murine cutaneous wound model. Wound Repair Regen. 2009, 17 (3): 354-359. 10.1111/j.1524-475X.2009.00489.x.PubMedCrossRef Schierle CF, De la Garza M, Mustoe TA, Galiano RD: Staphylococcal biofilms impair wound healing by delaying reepithelialzation in a murine cutaneous wound model. Wound Repair Regen. 2009, 17 (3): 354-359. 10.1111/j.1524-475X.2009.00489.x.PubMedCrossRef
19.
go back to reference Loo AEK, Halliwell B: Effects of hydrogen peroxide in a keratinocyte-fibroblast co-culture model of wound healing. Biochem Bioph Res Co. 2012, 423 (2): 253-258. 10.1016/j.bbrc.2012.05.100.CrossRef Loo AEK, Halliwell B: Effects of hydrogen peroxide in a keratinocyte-fibroblast co-culture model of wound healing. Biochem Bioph Res Co. 2012, 423 (2): 253-258. 10.1016/j.bbrc.2012.05.100.CrossRef
20.
go back to reference Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med. 1999, 341 (10): 738-746. 10.1056/NEJM199909023411006.PubMedCrossRef Singer AJ, Clark RAF: Cutaneous wound healing. N Engl J Med. 1999, 341 (10): 738-746. 10.1056/NEJM199909023411006.PubMedCrossRef
22.
go back to reference Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli A, Ring J, Abeck D, Ollert M: Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003, 121 (6): 1389-1396. 10.1111/j.1523-1747.2003.12630.x.PubMedCrossRef Mempel M, Voelcker V, Kollisch G, Plank C, Rad R, Gerhard M, Schnopp C, Fraunberger P, Walli A, Ring J, Abeck D, Ollert M: Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol. 2003, 121 (6): 1389-1396. 10.1111/j.1523-1747.2003.12630.x.PubMedCrossRef
23.
go back to reference Cook H, Stephens P, Davis KJ, Harding KG, Thomas DW: Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000, 115 (2): 225-233. 10.1046/j.1523-1747.2000.00044.x.PubMedCrossRef Cook H, Stephens P, Davis KJ, Harding KG, Thomas DW: Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000, 115 (2): 225-233. 10.1046/j.1523-1747.2000.00044.x.PubMedCrossRef
24.
go back to reference Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badavias E, Falanga V: Dermal fibroblasts from venous ulcers are unresponsive to action of transforming growth factor-beta 1. J Dermatol Sci. 1997, 16 (1): 59-66. 10.1016/S0923-1811(97)00622-1.PubMedCrossRef Hasan A, Murata H, Falabella A, Ochoa S, Zhou L, Badavias E, Falanga V: Dermal fibroblasts from venous ulcers are unresponsive to action of transforming growth factor-beta 1. J Dermatol Sci. 1997, 16 (1): 59-66. 10.1016/S0923-1811(97)00622-1.PubMedCrossRef
25.
go back to reference Stojadinovic O, Brenn H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M: Molecular pathogenesis of chronic wounds: The role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Path. 2005, 167 (1): 59-69. 10.1016/S0002-9440(10)62953-7.PubMedPubMedCentralCrossRef Stojadinovic O, Brenn H, Vouthounis C, Lee B, Fallon J, Stallcup M, Merchant A, Galiano RD, Tomic-Canic M: Molecular pathogenesis of chronic wounds: The role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Path. 2005, 167 (1): 59-69. 10.1016/S0002-9440(10)62953-7.PubMedPubMedCentralCrossRef
26.
go back to reference Secor PA, Garth JA, Fleckman P, Olerud JE, Mclnnemey K, Stewart PS: Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol. 2011, 11 (1): 143-155. 10.1186/1471-2180-11-143.PubMedPubMedCentralCrossRef Secor PA, Garth JA, Fleckman P, Olerud JE, Mclnnemey K, Stewart PS: Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol. 2011, 11 (1): 143-155. 10.1186/1471-2180-11-143.PubMedPubMedCentralCrossRef
27.
go back to reference Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995, 57 (1): 289-300. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995, 57 (1): 289-300.
28.
go back to reference Granger DL, Hibbs JB, Broadnax LM: Urinary nitrate excretion in relation to murine macrophage activation: influence of dietary l-arginine and oral NG-monomethyl-l-arginine. J Immunol. 1991, 146: 1294-1302.PubMed Granger DL, Hibbs JB, Broadnax LM: Urinary nitrate excretion in relation to murine macrophage activation: influence of dietary l-arginine and oral NG-monomethyl-l-arginine. J Immunol. 1991, 146: 1294-1302.PubMed
29.
go back to reference Luo JD, Chen AF: Nitrix oxide: a newly discovered function on wound healing. Acta Pharmacol Sin. 2005, 26 (3): 259-264. 10.1111/j.1745-7254.2005.00058.x.PubMedCrossRef Luo JD, Chen AF: Nitrix oxide: a newly discovered function on wound healing. Acta Pharmacol Sin. 2005, 26 (3): 259-264. 10.1111/j.1745-7254.2005.00058.x.PubMedCrossRef
30.
go back to reference Rizk M, Witte MB, Barul A: Nitric oxide and wound healing. World J Surg. 2004, 28 (3): 301-306. 10.1007/s00268-003-7396-7.PubMedCrossRef Rizk M, Witte MB, Barul A: Nitric oxide and wound healing. World J Surg. 2004, 28 (3): 301-306. 10.1007/s00268-003-7396-7.PubMedCrossRef
31.
go back to reference Schaffer MR, Tantry U, Gross SS, Wasserkruc HL, Barbui A: Nitric oxide regulated wound healing. J Surg Res. 1996, 63 (1): 237-240. 10.1006/jsre.1996.0254.PubMedCrossRef Schaffer MR, Tantry U, Gross SS, Wasserkruc HL, Barbui A: Nitric oxide regulated wound healing. J Surg Res. 1996, 63 (1): 237-240. 10.1006/jsre.1996.0254.PubMedCrossRef
32.
go back to reference Frank S, Kampfer H, Wetzler C, Pfeilschifter J: Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Internantional. 2002, 61 (3): 882-888. 10.1046/j.1523-1755.2002.00237.x.CrossRef Frank S, Kampfer H, Wetzler C, Pfeilschifter J: Nitric oxide drives skin repair: novel functions of an established mediator. Kidney Internantional. 2002, 61 (3): 882-888. 10.1046/j.1523-1755.2002.00237.x.CrossRef
33.
go back to reference Jones ML, Ganapolsky JG, Labbe A, Wahl C, Prakash S: Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl Microbiol Biot. 2010, 88 (2): 401-407. 10.1007/s00253-010-2733-x.CrossRef Jones ML, Ganapolsky JG, Labbe A, Wahl C, Prakash S: Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Appl Microbiol Biot. 2010, 88 (2): 401-407. 10.1007/s00253-010-2733-x.CrossRef
34.
go back to reference Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. J Biol Chem. 1992, 267 (30): 21277-21280.PubMed Heck DE, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. J Biol Chem. 1992, 267 (30): 21277-21280.PubMed
35.
go back to reference Soneja A, Drews M, Malinski T: Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep. 2005, 57: 108-119.PubMed Soneja A, Drews M, Malinski T: Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol Rep. 2005, 57: 108-119.PubMed
36.
go back to reference Hashioka S, Klegeris A, Moni A, Kato T, Sawada M, McGreer PL, Kanba S: Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp Neurol. 2007, 206 (1): 33-42. 10.1016/j.expneurol.2007.03.022.PubMedCrossRef Hashioka S, Klegeris A, Moni A, Kato T, Sawada M, McGreer PL, Kanba S: Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide. Exp Neurol. 2007, 206 (1): 33-42. 10.1016/j.expneurol.2007.03.022.PubMedCrossRef
37.
go back to reference Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V: Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation. Am J Path. 2003, 162 (1): 203-211. 10.1016/S0002-9440(10)63811-4.PubMedPubMedCentralCrossRef Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V: Arginase 1 Overexpression in Psoriasis: Limitation of Inducible Nitric Oxide Synthase Activity as a Molecular Mechanism for Keratinocyte Hyperproliferation. Am J Path. 2003, 162 (1): 203-211. 10.1016/S0002-9440(10)63811-4.PubMedPubMedCentralCrossRef
38.
go back to reference Fletcher J: Differences between acute and chronic wounds and the role of wound bed preparation. Nurs Stand. 2008, 22 (24): 62-68. 10.7748/ns2008.02.22.24.62.c6412.PubMedCrossRef Fletcher J: Differences between acute and chronic wounds and the role of wound bed preparation. Nurs Stand. 2008, 22 (24): 62-68. 10.7748/ns2008.02.22.24.62.c6412.PubMedCrossRef
39.
go back to reference Schieven GL: The p38 kinase plays a central role in inflammation. Curr Top Med Chem. 2009, 9 (11): 1038-1048. 10.2174/156802609789630974.PubMedCrossRef Schieven GL: The p38 kinase plays a central role in inflammation. Curr Top Med Chem. 2009, 9 (11): 1038-1048. 10.2174/156802609789630974.PubMedCrossRef
40.
go back to reference Cuenda A, Rousseau S: P38 MAP-Kinases pathway regulation, function and role in human diseases. Biochemica Biophysica Acta. 2007, 1773 (8): 1358-1375. 10.1016/j.bbamcr.2007.03.010.CrossRef Cuenda A, Rousseau S: P38 MAP-Kinases pathway regulation, function and role in human diseases. Biochemica Biophysica Acta. 2007, 1773 (8): 1358-1375. 10.1016/j.bbamcr.2007.03.010.CrossRef
41.
go back to reference Newton K, Dixit VM: Signaling in Innate Immunity and Inflammation. Cold Spring Harb Perspect Biol. 2012, 4 (3): 1-19.CrossRef Newton K, Dixit VM: Signaling in Innate Immunity and Inflammation. Cold Spring Harb Perspect Biol. 2012, 4 (3): 1-19.CrossRef
42.
go back to reference Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines IL 6 and related molecules (IL1 and TNF). FASEB. 1990, 4 (11): 2860-2867. Akira S, Hirano T, Taga T, Kishimoto T: Biology of multifunctional cytokines IL 6 and related molecules (IL1 and TNF). FASEB. 1990, 4 (11): 2860-2867.
43.
go back to reference Banno T, Gazel A, Blumenberg M: Effects of tumor necrosis factor-α (TNF-α) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem. 2004, 279 (31): 32633-32642. 10.1074/jbc.M400642200.PubMedCrossRef Banno T, Gazel A, Blumenberg M: Effects of tumor necrosis factor-α (TNF-α) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem. 2004, 279 (31): 32633-32642. 10.1074/jbc.M400642200.PubMedCrossRef
44.
go back to reference Liu YX, Wang J, Guo J, Wu J, Lieberman HB, Yin Y: DUSP1 is controlled by p53 during cellular response to oxidative stress. Mol Cancer Res. 2008, 6 (4): 624-633. 10.1158/1541-7786.MCR-07-2019.PubMedCrossRef Liu YX, Wang J, Guo J, Wu J, Lieberman HB, Yin Y: DUSP1 is controlled by p53 during cellular response to oxidative stress. Mol Cancer Res. 2008, 6 (4): 624-633. 10.1158/1541-7786.MCR-07-2019.PubMedCrossRef
45.
go back to reference Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A: Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000, 275 (20): 15220-15225. 10.1074/jbc.275.20.15220.PubMedCrossRef Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A: Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 2000, 275 (20): 15220-15225. 10.1074/jbc.275.20.15220.PubMedCrossRef
46.
go back to reference Fahay TJ, Sherry B, Tracey KJ, van Deventer S, Jones WG, Minei JP: Cytokine production in a model of wound healing; the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine. 1990, 2 (2): 92-99. 10.1016/1043-4666(90)90002-B.CrossRef Fahay TJ, Sherry B, Tracey KJ, van Deventer S, Jones WG, Minei JP: Cytokine production in a model of wound healing; the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine. 1990, 2 (2): 92-99. 10.1016/1043-4666(90)90002-B.CrossRef
47.
go back to reference Trengove NJ, Bielefeldt-Ohmann H, Stacey MC: Analysis of acute and chronic wound environments: Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Rep Regen. 2000, 8: 13-25.CrossRef Trengove NJ, Bielefeldt-Ohmann H, Stacey MC: Analysis of acute and chronic wound environments: Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Rep Regen. 2000, 8: 13-25.CrossRef
48.
go back to reference Schnorr O, Suschek CV, Kolb-Bachofen V: The importance of cationic amino acid transporter expression in human skin. J Invest Dermatol. 2003, 120: 1016-1022. 10.1046/j.1523-1747.2003.12139.x.PubMedCrossRef Schnorr O, Suschek CV, Kolb-Bachofen V: The importance of cationic amino acid transporter expression in human skin. J Invest Dermatol. 2003, 120: 1016-1022. 10.1046/j.1523-1747.2003.12139.x.PubMedCrossRef
49.
go back to reference Falsetta ML, McEwan AG, Jennings MP, Apicella MA: Anaerobic metabolism occurs in the substrate of gonococcal biofilms and may be sustained in part by nitric acid. Infect and Immun. 2010, 78: 2320-2328. 10.1128/IAI.01312-09.CrossRef Falsetta ML, McEwan AG, Jennings MP, Apicella MA: Anaerobic metabolism occurs in the substrate of gonococcal biofilms and may be sustained in part by nitric acid. Infect and Immun. 2010, 78: 2320-2328. 10.1128/IAI.01312-09.CrossRef
50.
go back to reference Barraud N, Schleheck D, Klebensberger J, Webb JS, Hassat DJ, Rice SA, Kjelleberg S: Nitric oxide signaling in Pseudomonas aeriginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol. 2009, 191 (23): 7333-7342. 10.1128/JB.00975-09.PubMedPubMedCentralCrossRef Barraud N, Schleheck D, Klebensberger J, Webb JS, Hassat DJ, Rice SA, Kjelleberg S: Nitric oxide signaling in Pseudomonas aeriginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol. 2009, 191 (23): 7333-7342. 10.1128/JB.00975-09.PubMedPubMedCentralCrossRef
51.
go back to reference Cai W, Wu J, Xi C, Meyerhoff ME: Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coating. Biomaterials. 2012, 33 (32): 7933-7944. 10.1016/j.biomaterials.2012.07.027.PubMedPubMedCentralCrossRef Cai W, Wu J, Xi C, Meyerhoff ME: Diazeniumdiolate-doped poly(lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coating. Biomaterials. 2012, 33 (32): 7933-7944. 10.1016/j.biomaterials.2012.07.027.PubMedPubMedCentralCrossRef
52.
go back to reference Nakane A, Okamoto M, Asano M, Kohanawa M, Minigawa T: Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun. 1995, 63: 1165-1172.PubMedPubMedCentral Nakane A, Okamoto M, Asano M, Kohanawa M, Minigawa T: Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun. 1995, 63: 1165-1172.PubMedPubMedCentral
53.
go back to reference Fournier B, Philpott DJ: Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005, 18: 521-540. 10.1128/CMR.18.3.521-540.2005.PubMedPubMedCentralCrossRef Fournier B, Philpott DJ: Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005, 18: 521-540. 10.1128/CMR.18.3.521-540.2005.PubMedPubMedCentralCrossRef
54.
go back to reference Konig B, Prevost G, Piemont Y, Konig W: Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis. 1995, 171: 607-613. 10.1093/infdis/171.3.607.PubMedCrossRef Konig B, Prevost G, Piemont Y, Konig W: Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis. 1995, 171: 607-613. 10.1093/infdis/171.3.607.PubMedCrossRef
55.
go back to reference Walev I, Weller U, Strauch S, Foster T, Bhakdi S: Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect Immun. 1996, 64: 2974-2979.PubMedPubMedCentral Walev I, Weller U, Strauch S, Foster T, Bhakdi S: Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect Immun. 1996, 64: 2974-2979.PubMedPubMedCentral
56.
go back to reference Wang JE, Jorgensen PF, Almӧf M, Thiermermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model. Infect Immun. 2000, 81: 3965-3970.CrossRef Wang JE, Jorgensen PF, Almӧf M, Thiermermann C, Foster SJ, Aasen AO, Solberg R: Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model. Infect Immun. 2000, 81: 3965-3970.CrossRef
57.
go back to reference Wang JE, Dahle MK, Yndestad A, Bauer I, McDonald MC, Aukrust P, Foster SJ, Bauer M, Aasen AO, Thiermermann C: Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med. 2004, 32: 546-552. 10.1097/01.CCM.0000109775.22138.8F.PubMedCrossRef Wang JE, Dahle MK, Yndestad A, Bauer I, McDonald MC, Aukrust P, Foster SJ, Bauer M, Aasen AO, Thiermermann C: Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit Care Med. 2004, 32: 546-552. 10.1097/01.CCM.0000109775.22138.8F.PubMedCrossRef
58.
go back to reference Dauwalder O, Thomas D, Ferry T, Debard A-L, Badiou C, Vandenesch F, Etienne J, Lina G, Monneret G: Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leuk Biol. 2006, 80: 753-758. 10.1189/jlb.0306232.CrossRef Dauwalder O, Thomas D, Ferry T, Debard A-L, Badiou C, Vandenesch F, Etienne J, Lina G, Monneret G: Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock. J Leuk Biol. 2006, 80: 753-758. 10.1189/jlb.0306232.CrossRef
Metadata
Title
Early effects of Staphylococcus aureus biofilm secreted products on inflammatory responses of human epithelial keratinocytes
Authors
Amy Tankersley
Mark Barton Frank
Melissa Bebak
Robert Brennan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2014
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-11-17

Other articles of this Issue 1/2014

Journal of Inflammation 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.